The staff of Contemporary Pediatrics has packed and is ready to depart for American Academy of Pediatrics National Conference & Exhibition in the nation’s capital.
The staff of Contemporary Pediatrics has packed and is ready to depart for American Academy of Pediatrics National Conference & Exhibition in the nation’s capital October 24 - 27. While there, we’ll be bringing you daily reports on sessions of value to your practice in the following areas:
Stay tuned for even more AAP conference coverage in our November 2015 issue!
Toxicity related to THC dose in pediatric edible cannabis ingestions
October 3rd 2023The degree of toxicity following pediatric ingestion of THC was correlated to the dose of THC, as ingestions of 1.7 mg/kg or more was predictive of severe and prolonged toxicity, according to a study published in Pediatrics.
FDA approves tocilizumab-bavi as biosimilar for PJIA, SJIA in children 2 years and up
October 2nd 2023Tocilizumab-bavi (Tofidence; Biogen) demonstrated a biosimilarity to tocilizumab (Actemra; Genentech) based on multifaceted clinical and non-clinical data for polyarticular juvenile idiopathic arthritis (PJIA) and systemic juvenile idiopathic arthritis (sJIA) in children aged 2 years and up. This makes it the first tocilizumab biosimilar to be FDA-approved in the United States, according to Biogen.
2 Clarke Drive
Cranbury, NJ 08512